Short-Term and Long-Term Safety Analyses of Brexpiprazole for Agitation Associated with Dementia due to Alzheimer’s Disease: Timing and Duration of Adverse Events - Poll - MDSpire

Short-Term and Long-Term Safety Analyses of Brexpiprazole for Agitation Associated with Dementia due to Alzheimer’s Disease: Timing and Duration of Adverse Events

  • By

  • Anton P. Porsteinsson

  • Sanjeda R. Chumki

  • David Wang

  • Pedro Such

  • Anton M. Palma

  • Zhen Zhang

  • Alpesh Shah

  • Uwa Kalu

  • C. Brendan Montano

  • April 10, 2026

  • 0 min

Share

Original Source(s)

Short-Term and Long-Term Safety Analyses of Brexpiprazole for Agitation Associated with Dementia due to Alzheimer’s Disease: Timing and Duration of Adverse Events

  • by Anton P. Porsteinsson, Sanjeda R. Chumki, David Wang, Pedro Such, Anton M. Palma, Zhen Zhang, Alpesh Shah, Uwa Kalu, C. Brendan Montano

  • April 10, 2026

Related Content

Targeting the miR-32533/CREB5 axis: a promising immunomodulatory and therapeutic strategy for Alzheimer’s disease

Makary’s departure and Cassidy’s tenuous Senate seat

ARPA-H Launches New Program to Deliver Rigorous, Gold-Standard Research Faster